Proximal Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea in the OSPREY Study: A Randomized Controlled Trial
Here is the take-home point. Nearly six in ten treated patients met the response bar at seven months, against roughly one in seven with the device switched off. That is a real, randomized effect, for an investigational proximal device made by LivaNova. For a high-volume Inspire implanter, as in Dr. Nord's practice, the decision this paper touches is counseling. Picture a patient who cannot tolerate positive airway pressure and asks about every implant option. So what does the paper add? First, that patient can now be told that a different, investigational implant has a randomized trial behind…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.